Presentations

NOX Corporate Presentation FNN-Shaw&Partners Investor Event
Noxopharm Corporate Presentation for Public Briefing
Noxopharm CEO Interview Updates the Company's Current Research and Development Program
Noxopharm CEO Interview on near-completed NOX66 chemotherapy trial CEP-1
Noxopharm CEO Interview with FNN on the Company's NOX66 and Radiotherapy Clinical Programs
TROG Annual Scientific Meeting - Noxopharm Presentation 21.3.18
Corporate Presentation - Post Interim Clinical Data Release
Noxopharm CEO talks to FNN about CEP-1 Clinical Study Interim Data from 2018 TAT Congress in Paris, March 5-7
NOX Open Briefing Corporate Presentation
Noxopharm Limited 2017 AGM Webcast, November 27, 2017